Selected research
Industry Growth & Trends
Global Tissue Fixative Industry Growth and Trends Forecast to 2032
Market perspective
The global Tissue Fixative market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Tissue Fixative is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Tissue Fixative is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Tissue Fixative is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Tissue Fixative include Thermo Fisher Scientific, Liaoshiyuan Biomedical Technology, Leica Biosystems, Servicebio, Saiguo Biotechnology, Boster Biological Technology, Abcam, Leagene and Beyotime, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Tissue Fixative market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Tissue Fixative market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Tissue Fixative market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Tissue Fixative.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Tissue Fixative market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Tissue Fixative Market by Company
Thermo Fisher Scientific
Liaoshiyuan Biomedical Technology
Leica Biosystems
Servicebio
Saiguo Biotechnology
Boster Biological Technology
Abcam
Leagene
Beyotime
Sangon Biotech
Biosharp
Absin
Wako
Biotium
R&D Systems
Yeasen Biotechnology
Bestbio
Tissue Fixative Segment by Type
DEPC-free
DEPC-containing
Tissue Fixative Segment by Application
Immunohistochemistry
Immunocytochemistry
Other
Tissue Fixative Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tissue Fixative market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Tissue Fixative and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tissue Fixative.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Tissue Fixative manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Tissue Fixative in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- DEPC-free
- DEPC-containing
Applications
- Immunohistochemistry
- Immunocytochemistry
- Other
Companies covered
- Thermo Fisher Scientific
- Liaoshiyuan Biomedical Technology
- Leica Biosystems
- Servicebio
- Saiguo Biotechnology
- Boster Biological Technology
- Abcam
- Leagene
- Beyotime
- Sangon Biotech
- Biosharp
- Absin
- Wako
- Biotium
- R&D Systems
- Yeasen Biotechnology
- Bestbio
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Tissue Fixative Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Tissue Fixative Sales Estimates and Forecasts (2021-2032)
- 1.3 Tissue Fixative Market by Type
- 1.3.1 DEPC-free
- 1.3.2 DEPC-containing
- 1.4 Global Tissue Fixative Market Size by Type
- 1.4.1 Global Tissue Fixative Market Size Overview by Type (2021-2032)
- 1.4.2 Global Tissue Fixative Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Tissue Fixative Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Tissue Fixative Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Tissue Fixative Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Tissue Fixative Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Tissue Fixative Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Tissue Fixative Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Tissue Fixative Industry Trends
- 2.2 Tissue Fixative Industry Drivers
- 2.3 Tissue Fixative Industry Opportunities and Challenges
- 2.4 Tissue Fixative Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Tissue Fixative Revenue (2021-2026)
- 3.2 Global Top Players by Tissue Fixative Sales (2021-2026)
- 3.3 Global Top Players by Tissue Fixative Price (2021-2026)
- 3.4 Global Tissue Fixative Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Tissue Fixative Major Company Production Sites & Headquarters
- 3.6 Global Tissue Fixative Company, Product Type & Application
- 3.7 Global Tissue Fixative Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Tissue Fixative Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Tissue Fixative Players Market Share by Revenue in 2025
- 3.8.3 2025 Tissue Fixative Tier 1, Tier 2, and Tier 3
4 Tissue Fixative Regional Status and Outlook
- 4.1 Global Tissue Fixative Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Tissue Fixative Historic Market Size by Region
- 4.2.1 Global Tissue Fixative Sales in Volume by Region (2021-2026)
- 4.2.2 Global Tissue Fixative Sales in Value by Region (2021-2026)
- 4.2.3 Global Tissue Fixative Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Tissue Fixative Forecasted Market Size by Region
- 4.3.1 Global Tissue Fixative Sales in Volume by Region (2027-2032)
- 4.3.2 Global Tissue Fixative Sales in Value by Region (2027-2032)
- 4.3.3 Global Tissue Fixative Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Tissue Fixative by Application
- 5.1 Tissue Fixative Market by Application
- 5.1.1 Immunohistochemistry
- 5.1.2 Immunocytochemistry
- 5.1.3 Other
- 5.2 Global Tissue Fixative Market Size by Application
- 5.2.1 Global Tissue Fixative Market Size Overview by Application (2021-2032)
- 5.2.2 Global Tissue Fixative Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Tissue Fixative Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Tissue Fixative Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Tissue Fixative Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Tissue Fixative Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Tissue Fixative Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Tissue Fixative Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Thermo Fisher Scientific
- 6.1.1 Thermo Fisher Scientific Company Information
- 6.1.2 Thermo Fisher Scientific Business Overview
- 6.1.3 Thermo Fisher Scientific Tissue Fixative Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Thermo Fisher Scientific Tissue Fixative Product Portfolio
- 6.1.5 Thermo Fisher Scientific Recent Developments
- 6.2 Liaoshiyuan Biomedical Technology
- 6.2.1 Liaoshiyuan Biomedical Technology Company Information
- 6.2.2 Liaoshiyuan Biomedical Technology Business Overview
- 6.2.3 Liaoshiyuan Biomedical Technology Tissue Fixative Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Liaoshiyuan Biomedical Technology Tissue Fixative Product Portfolio
- 6.2.5 Liaoshiyuan Biomedical Technology Recent Developments
- 6.3 Leica Biosystems
- 6.3.1 Leica Biosystems Company Information
- 6.3.2 Leica Biosystems Business Overview
- 6.3.3 Leica Biosystems Tissue Fixative Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Leica Biosystems Tissue Fixative Product Portfolio
- 6.3.5 Leica Biosystems Recent Developments
- 6.4 Servicebio
- 6.4.1 Servicebio Company Information
- 6.4.2 Servicebio Business Overview
- 6.4.3 Servicebio Tissue Fixative Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Servicebio Tissue Fixative Product Portfolio
- 6.4.5 Servicebio Recent Developments
- 6.5 Saiguo Biotechnology
- 6.5.1 Saiguo Biotechnology Company Information
- 6.5.2 Saiguo Biotechnology Business Overview
- 6.5.3 Saiguo Biotechnology Tissue Fixative Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Saiguo Biotechnology Tissue Fixative Product Portfolio
- 6.5.5 Saiguo Biotechnology Recent Developments
- 6.6 Boster Biological Technology
- 6.6.1 Boster Biological Technology Company Information
- 6.6.2 Boster Biological Technology Business Overview
- 6.6.3 Boster Biological Technology Tissue Fixative Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Boster Biological Technology Tissue Fixative Product Portfolio
- 6.6.5 Boster Biological Technology Recent Developments
- 6.7 Abcam
- 6.7.1 Abcam Company Information
- 6.7.2 Abcam Business Overview
- 6.7.3 Abcam Tissue Fixative Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Abcam Tissue Fixative Product Portfolio
- 6.7.5 Abcam Recent Developments
- 6.8 Leagene
- 6.8.1 Leagene Company Information
- 6.8.2 Leagene Business Overview
- 6.8.3 Leagene Tissue Fixative Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Leagene Tissue Fixative Product Portfolio
- 6.8.5 Leagene Recent Developments
- 6.9 Beyotime
- 6.9.1 Beyotime Company Information
- 6.9.2 Beyotime Business Overview
- 6.9.3 Beyotime Tissue Fixative Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Beyotime Tissue Fixative Product Portfolio
- 6.9.5 Beyotime Recent Developments
- 6.10 Sangon Biotech
- 6.10.1 Sangon Biotech Company Information
- 6.10.2 Sangon Biotech Business Overview
- 6.10.3 Sangon Biotech Tissue Fixative Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Sangon Biotech Tissue Fixative Product Portfolio
- 6.10.5 Sangon Biotech Recent Developments
- 6.11 Biosharp
- 6.11.1 Biosharp Company Information
- 6.11.2 Biosharp Business Overview
- 6.11.3 Biosharp Tissue Fixative Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 Biosharp Tissue Fixative Product Portfolio
- 6.11.5 Biosharp Recent Developments
- 6.12 Absin
- 6.12.1 Absin Company Information
- 6.12.2 Absin Business Overview
- 6.12.3 Absin Tissue Fixative Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 Absin Tissue Fixative Product Portfolio
- 6.12.5 Absin Recent Developments
- 6.13 Wako
- 6.13.1 Wako Company Information
- 6.13.2 Wako Business Overview
- 6.13.3 Wako Tissue Fixative Sales, Revenue and Gross Margin (2021-2026)
- 6.13.4 Wako Tissue Fixative Product Portfolio
- 6.13.5 Wako Recent Developments
- 6.14 Biotium
- 6.14.1 Biotium Company Information
- 6.14.2 Biotium Business Overview
- 6.14.3 Biotium Tissue Fixative Sales, Revenue and Gross Margin (2021-2026)
- 6.14.4 Biotium Tissue Fixative Product Portfolio
- 6.14.5 Biotium Recent Developments
- 6.15 R&D Systems
- 6.15.1 R&D Systems Company Information
- 6.15.2 R&D Systems Business Overview
- 6.15.3 R&D Systems Tissue Fixative Sales, Revenue and Gross Margin (2021-2026)
- 6.15.4 R&D Systems Tissue Fixative Product Portfolio
- 6.15.5 R&D Systems Recent Developments
- 6.16 Yeasen Biotechnology
- 6.16.1 Yeasen Biotechnology Company Information
- 6.16.2 Yeasen Biotechnology Business Overview
- 6.16.3 Yeasen Biotechnology Tissue Fixative Sales, Revenue and Gross Margin (2021-2026)
- 6.16.4 Yeasen Biotechnology Tissue Fixative Product Portfolio
- 6.16.5 Yeasen Biotechnology Recent Developments
- 6.17 Bestbio
- 6.17.1 Bestbio Company Information
- 6.17.2 Bestbio Business Overview
- 6.17.3 Bestbio Tissue Fixative Sales, Revenue and Gross Margin (2021-2026)
- 6.17.4 Bestbio Tissue Fixative Product Portfolio
- 6.17.5 Bestbio Recent Developments
7 North America by Country
- 7.1 North America Tissue Fixative Sales by Country
- 7.1.1 North America Tissue Fixative Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Tissue Fixative Sales by Country (2021-2026)
- 7.1.3 North America Tissue Fixative Sales Forecast by Country (2027-2032)
- 7.2 North America Tissue Fixative Market Size by Country
- 7.2.1 North America Tissue Fixative Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Tissue Fixative Market Size by Country (2021-2026)
- 7.2.3 North America Tissue Fixative Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Tissue Fixative Sales by Country
- 8.1.1 Europe Tissue Fixative Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Tissue Fixative Sales by Country (2021-2026)
- 8.1.3 Europe Tissue Fixative Sales Forecast by Country (2027-2032)
- 8.2 Europe Tissue Fixative Market Size by Country
- 8.2.1 Europe Tissue Fixative Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Tissue Fixative Market Size by Country (2021-2026)
- 8.2.3 Europe Tissue Fixative Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Tissue Fixative Sales by Country
- 9.1.1 Asia-Pacific Tissue Fixative Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Tissue Fixative Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Tissue Fixative Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Tissue Fixative Market Size by Country
- 9.2.1 Asia-Pacific Tissue Fixative Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Tissue Fixative Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Tissue Fixative Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Tissue Fixative Sales by Country
- 10.1.1 South America Tissue Fixative Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Tissue Fixative Sales by Country (2021-2026)
- 10.1.3 South America Tissue Fixative Sales Forecast by Country (2027-2032)
- 10.2 South America Tissue Fixative Market Size by Country
- 10.2.1 South America Tissue Fixative Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Tissue Fixative Market Size by Country (2021-2026)
- 10.2.3 South America Tissue Fixative Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Tissue Fixative Sales by Country
- 11.1.1 Middle East and Africa Tissue Fixative Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Tissue Fixative Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Tissue Fixative Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Tissue Fixative Market Size by Country
- 11.2.1 Middle East and Africa Tissue Fixative Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Tissue Fixative Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Tissue Fixative Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Tissue Fixative Value Chain Analysis
- 12.1.1 Tissue Fixative Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Tissue Fixative Production Mode & Process
- 12.2 Tissue Fixative Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Tissue Fixative Distributors
- 12.2.3 Tissue Fixative Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst